EU Strategy on COVID-19 vaccines must guarantee safety and accessibility for all
Parliament's Committee responsible for public health debated how to support efforts to develop and manufacture COVID-19 vaccines, together with Commissioner Kyriakides.
- Commission proposes a temporary derogation from clinical trials involving GMOs
- The Vaccine Alliance by four EU member states complementary to EU Strategy
- Communication on the “risk of a second wave” issued by Commission on 15 July
A joint EU Strategy is the most efficient way to develop a safe COVID-19 vaccine ©European Union 2020/EC-Slovak Academy of Sciences
When presenting the new European strategy for COVID-19 vaccines to the Committee for Environment, Public Health and Food Safety on Monday, Health Commissioner Stella Kyriakides underlined that a joint EU Strategy is the most efficient and solidary way to develop, manufacture and distribute a safe COVID-19 vaccine accessible for all. She also said that all 27 member states expressed their support for the Commission to secure Advance Purchase Agreements with vaccine producers via the Emergency Support Instrument.
Temporary derogation from clinical trials on GMOs
To facilitate the development, authorisation and consequently availability of COVID-19 vaccines and treatments, the Commission proposal from 17 June proposes to establish a temporary derogation from certain rules for clinical trials of drugs involving GMOs.
While Members welcomed the need to adapt the rules, they stressed that standards for vaccine quality, safety and efficacy must be maintained.
The Vaccine Alliance by France, Germany, Italy, and the Netherlands
Some MEPs asked about the division of labour between the EU and its member states and enquired how the Commission viewed the Vaccine Alliance created by France, Germany, Italy, and the Netherlands, which aims to secure the supply of a potential COVID-19 vaccine for Europe. The Commissioner replied that the Vaccine Alliance was an inclusive initiative by four member states and open to all.
A public hearing on “How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges” is tentatively scheduled to take place by videoconference before the summer recess.
Watch the full recording of the debate here.
Latest News from
Declaration of the High Representative on behalf of the European Union on the adoption by China’s National People’s Congress of a National Security Legislation on Hong Kong.02/07/2020 16:43:00
The Standing Committee of China’s National People’s Congress adopted the National Security Law in Hong Kong on 30 June and subsequently promulgated it in Hong Kong the same day.
Vaccine against Ebola: Commission grants new market authorisations02/07/2020 15:25:00
The European Commission yesterday adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola.
Commission presents European Skills Agenda for sustainable competitiveness, social fairness and resilience02/07/2020 14:43:00
The Commission yesterday presented the European Skills Agenda for sustainable competitiveness, social fairness and resilience.
Commission launches Youth Employment Support: a bridge to jobs for the next generation02/07/2020 13:25:00
The European Commission is taking action to give young people all possible opportunities to develop their full potential to shape the future of the EU, and thrive in the green and digital transitions.
Questions and answers: European Skills Agenda for sustainable competitiveness, social fairness and resilience02/07/2020 12:38:00
Skills are key for sustainable competitiveness, resilience and ensuring social fairness for all. Businesses need workers with the skills required to master the green and digital transitions, and people need to be able to get the right education and training to thrive in life.
“Together for Europe’s recovery”: Germany takes over Council presidency02/07/2020 11:33:00
While the corona pandemic continues, Germany took over the six-month presidency of the Council of the EU on 1 July. We asked German MEPs for their expectations.
Modernising judicial cooperation across borders: Presidency and Parliament reach provisional agreement on the taking of evidence and the service of documents regulations02/07/2020 09:25:00
The EU is working to modernise cross-border exchanges between authorities through digitalisation to improve judicial cooperation in civil and commercial matters.
Council agrees to start lifting travel restrictions for residents of some third countries01/07/2020 16:43:00
The Council yesterday adopted a recommendation on the gradual lifting of the temporary restrictions on non-essential travel into the EU.
Commission welcomes confirmation of provisional agreement to strengthen collective redress in the EU01/07/2020 15:25:00
The Council yesterday endorsed a provisional agreement on EU-wide rules for the protection of collective interest of consumers recently concluded with the European Parliament.